These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9467537)

  • 1. Treatment of orthostatic hypotension with midodrine and octreotide.
    Hoeldtke RD; Horvath GG; Bryner KD; Hobbs GR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):339-43. PubMed ID: 9467537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.
    Fouad-Tarazi FM; Okabe M; Goren H
    Am J Med; 1995 Dec; 99(6):604-10. PubMed ID: 7503082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.
    Low PA; Gilden JL; Freeman R; Sheng KN; McElligott MA
    JAMA; 1997 Apr; 277(13):1046-51. PubMed ID: 9091692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary experience with midodrine in kidney/pancreas transplant patients with orthostatic hypotension.
    Hurst GC; Somerville KT; Alloway RR; Gaber AO; Stratta RJ
    Clin Transplant; 2000 Feb; 14(1):42-7. PubMed ID: 10693634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension.
    McClellan KJ; Wiseman LR; Wilde MI
    Drugs Aging; 1998 Jan; 12(1):76-86. PubMed ID: 9467688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midodrine prescribed to improve recurrent post-spaceflight orthostatic hypotension.
    Platts SH; Ziegler MG; Waters WW; Mitchell BM; Meck JV
    Aviat Space Environ Med; 2004 Jun; 75(6):554-6. PubMed ID: 15198285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients?
    Cruz DN; Mahnensmith RL; Perazella MA
    Am J Kidney Dis; 1997 Dec; 30(6):772-9. PubMed ID: 9398120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of orthostatic hypotension with octreotide.
    Hoeldtke RD; Israel BC
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1051-9. PubMed ID: 2723026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).
    Kaufmann H; Brannan T; Krakoff L; Yahr MD; Mandeli J
    Neurology; 1988 Jun; 38(6):951-6. PubMed ID: 2452997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine.
    Hoeldtke RD; Bryner KD; Hoeldtke ME; Hobbs G
    Clin Auton Res; 2006 Dec; 16(6):390-5. PubMed ID: 17036177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
    Ramirez CE; Okamoto LE; Arnold AC; Gamboa A; Diedrich A; Choi L; Raj SR; Robertson D; Biaggioni I; Shibao CA
    Hypertension; 2014 Dec; 64(6):1235-40. PubMed ID: 25185131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midodrine for orthostatic hypotension.
    Med Lett Drugs Ther; 1997 Jun; 39(1003):59-60. PubMed ID: 9205432
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged supine hypertension due to midodrine use in an orthostatic hypotensive child.
    Olgar S; Omeroglu RE
    Pediatr Cardiol; 2007; 28(4):309-10. PubMed ID: 17530320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension.
    Cruz DN
    Expert Opin Pharmacother; 2000 May; 1(4):835-40. PubMed ID: 11249519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.
    Smith W; Wan H; Much D; Robinson AG; Martin P
    Clin Auton Res; 2016 Aug; 26(4):269-77. PubMed ID: 27372462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of octreotide on experimental orthostatic neurogenic hypotension].
    Verwaerde P; Bordet R; Portolan G; Tran MA; Marques MA; Montastruc JL; Sénard JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1097-1101. PubMed ID: 8949386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Treatment of Primary Orthostatic Hypotension.
    Hale GM; Valdes J; Brenner M
    Ann Pharmacother; 2017 May; 51(5):417-428. PubMed ID: 28092986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.
    Jankovic J; Gilden JL; Hiner BC; Kaufmann H; Brown DC; Coghlan CH; Rubin M; Fouad-Tarazi FM
    Am J Med; 1993 Jul; 95(1):38-48. PubMed ID: 7687093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure.
    Schrage WG; Eisenach JH; Dinenno FA; Roberts SK; Johnson CP; Sandroni P; Low PA; Joyner MJ
    J Appl Physiol (1985); 2004 Nov; 97(5):1978-84. PubMed ID: 15273244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midodrine in neurogenic orthostatic hypotension. A new treatment.
    Gilden JL
    Int Angiol; 1993 Jun; 12(2):125-31. PubMed ID: 7690383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.